Clinical Trials Browser

Expanded_access × Neoplasms × enzalutamide × Clear all

NCT01606982 2017-02-17

Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Approved for marketing

Neoplasms